Akers Biosciences (AKER) Stock Price, Quote, News and Overview
NASDAQ:AKER - Nasdaq -
AKER Quote, Performance and Key Statistics
2.47
-0.26 (-9.52%)
The current stock price of AKER is 2.47 null. In the past month the price decreased by -29.83%. In the past year, price decreased by -27.78%.
About AKER
Company Profile
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Company Info
Akers Biosciences
201 GROVE RD
THOROFARE NJ 08086
CEO: Christopher C. Schreiber
Phone: 856-848-8698
Akers Biosciences / AKER FAQ
What is the stock price of Akers Biosciences today?
The current stock price of AKER is 2.47 null. The price decreased by -9.52% in the last trading session.
What is the ticker symbol for Akers Biosciences stock?
The exchange symbol of Akers Biosciences is AKER and it is listed on the Nasdaq exchange.
On which exchange is AKER stock listed?
AKER stock is listed on the Nasdaq exchange.
What is Akers Biosciences worth?
Akers Biosciences (AKER) has a market capitalization of 41.13M null. This makes AKER a Nano Cap stock.
What are the support and resistance levels for Akers Biosciences (AKER) stock?
Akers Biosciences (AKER) has a resistance level at 3.32. Check the full technical report for a detailed analysis of AKER support and resistance levels.
Should I buy Akers Biosciences (AKER) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AKER, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AKER, evaluating the profitability, health, valuation and growth aspects
- Akers Biosciences (AKER) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Akers Biosciences (AKER) Sales and EPS estimates to see what analysts future expectations are.
- Akers Biosciences (AKER) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Akers Biosciences (AKER) Insider and Institutional Ownership to learn about the owners and their transactions.
- Akers Biosciences (AKER) Stock Chart to make your own analysis
- Akers Biosciences (AKER) Latest news and press-releases to stay up to date.
Does Akers Biosciences (AKER) stock pay dividends?
AKER does not pay a dividend.
When does Akers Biosciences (AKER) report earnings?
Akers Biosciences (AKER) will report earnings on 2022-02-28, after the market close.
What is the Price/Earnings (PE) ratio of Akers Biosciences (AKER)?
Akers Biosciences (AKER) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.25).
AKER Technical Analysis
AKER Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AKER. While AKER has a great health rating, there are worries on its profitability.
AKER Financial Highlights
Over the last trailing twelve months AKER reported a non-GAAP Earnings per Share(EPS) of -4.25. The EPS increased by 17.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.72% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |